Estimating Potential for Drug Budget Reallocation Following Expiration of Exclusivity of Pharmaceutical Products
**Background:** The prioritization of public funds in an equitable and ethically sound manner along with efficient budget allocation are key challenges for governments and budget holders. Following the introduction of generics/biosimilars, the potential total budget made available for reallocation r...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Columbia Data Analytics, LLC
2022-02-01
|
| Series: | Journal of Health Economics and Outcomes Research |
| Online Access: | https://jheor.scholasticahq.com/article/29624-estimating-potential-for-drug-budget-reallocation-following-expiration-of-exclusivity-of-pharmaceutical-products.pdf |